These conclusions are highly consistent with our experimental results and indirectly demonstrate that low DDX3 expression promotes the proliferation and metastasis of CRC cells by inhibiting E-cadherin and activating β-catenin signaling through the MAPK pathway. The gene discussed is DDX3X; the disease is colorectal carcinoma.